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C A S E
R E P O R T
Introduction
Uterine arteriovenous malformations (AVMs) are
rare disorders that can pose significant risks to pa-
tients. The clinical symptoms are highly variable,
and can range from episodes of menorrhagia to
life-threatening vaginal bleeding. AVMs occur most
often after uterine trauma, surgery, endometrial car-
cinoma, cervical carcinoma, or gestational tropho-
blastic disease (GTD) [1–5]. Pelvic angiography has
been the “gold standard” for confirmation of uter-
ine AVMs [6–9], but it is invasive and thus is rarely
performed for purely diagnostic procedures. Ultra-
sonography remains the most commonly used tool
for investigating abnormal uterine masses. We pres-
ent a case of uterine AVMs diagnosed with 2D and
3D ultrasonography.
Case Report
A 36-year-old female, gravida 4, para 1, visited our
outpatient clinic complaining of intermittent vagi-
nal bleeding for 5 months. Her medical history
revealed that she had a dilation and curettage
(D&C) due to a delayed miscarriage about 2 years
beforehand. After the surgery of D&C, she became
pregnant again and had an uneventful course until
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the second trimester, when intermittent antepar-
tum hemorrhaging began. In the third trimester, a
progressively enlarged hypervascular fundal tumor
was found. In spite of medication and hospitaliza-
tion, her hemorrhaging persisted. At term, a female
infant was born without incident, but then the
mother developed postpartum hemorrhaging. The
bleeding was controlled with conservative treat-
ment, including oxytocin and blood component
therapy. After this, the patient had several episodes
of moderate painless uterine bleeding unrelated to
her menstrual periods.
At our hospital, 2D ultrasonography revealed 
a heterogeneous mass over the fundal area of the
myometrium. With color Doppler mapping, a tan-
gle of vessels with high-velocity flow was found
(Fig. 1). Also 3D ultrasonography with power
Doppler mapping was a used to delineate the
uterine mass. A commercially available GE Voluson
730 Expert Ultrasonography System Scanner (GE
Medical Systems, Milwaukee, WI) equipped with 
a multifrequency transvaginal volumetric probe
(3–9 megahertz, or MHz) was used.
The 3D ultrasonography and power Doppler
imaging method used to visualize the uterine fun-
dal mass was similar to that described in previous
studies [10]. We set the color area of the 2D power
Doppler to cover the area of the uterine mass. The
volume angle was set at 65 degrees. During data
acquisition, the transducer was not moved and the
patient was asked to hold her breath for 5 to 7 sec-
onds. The 3D ultrasonography with surface render-
ing mode revealed a tangle of tortuous vessels. The
Virtual Organ Computer-aided Analysis (VOCAL)
program was also applied (Fig. 2). The measured
vascularization index (VI) was 73.684; the flow
index (FI) was 70.23; and the vascularization-flow
index (VFI) was 51.748. The value of VI represented
the blood vessels within the tissue, expressed as a
percentage. The value of FI showed the average
blood flow intensity. The VFI is the average color
value of all the grey and color regions, representing
both blood flow and vascularization. These results
indicated high blood flow and moderate amounts
of vascularization in the uterine AVM lesion. These
3D ultrasonography findings increased our confi-
dence in the diagnosis of AVM (Fig. 3).
To exclude the possibility of GTD, we measured
the patient’s serum human chorionic gonadotropin
(hCG) level. The serum hCG level was less than
1.2 mIU/mL, and an AVM was strongly suspected.
Magnetic resonance imaging (MRI) showed mas-
sively dilated vessels on the fundal region with an
early venous return from a markedly dilated left
renal vein, which also suggested an AVM. Trans-
catheter arterial embolization (TAE) was suggested,
but the patient declined the procedure and re-
quested a hysterectomy instead. Subsequent patho-
logic examination proved the diagnosis of uterine
AVMs (Fig. 4).
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Fig. 1. Tangle of vessels in 2D ultrasound with color Doppler
mapping. Blood flow velocity waveforms within the aneurysm-
like structure showing the typical turbulent flow.
Fig. 2. The uterine AVM mass was presented and estimated
with 3D power Doppler image ultrasound.
Discussion
All uterine AVMs are the result of abnormal com-
munication between arteries and veins. Large num-
bers of morphologically abnormal vessels secondary
to aberrant angiogenesis are usually detected by
pathologic examination [2,11]. Uterine AVMs are
infrequent, and the true incidence is still unknown
[6–8]. When O’Brien et al [9] performed pelvic
ultrasonography in 464 patients with abnormal
uterine bleeding, they found 21 uterine AVMs, an
approximate incidence of 4.5%.
The most common clinical presentation of AVMs
is bleeding. However, the bleeding is widely varied,
ranging from menometrorrhagia to severe and even
life-threatening bleeding. The causes can be con-
genital or acquired. Acquired malformations are
mainly due to previous uterine trauma or surgery,
such as curettage or pelvic surgery, or are caused by
endometrial and cervical carcinoma in situ, mater-
nal diethylstilbestrol (DES) exposure, or GTD [1–5].
In our case, although a D&C was performed 
2 years before the AVMs occurred, we felt the
D&C was the cause of the subsequent AVMs. One
possible explanation for the long interval between
injury and symptoms was that the first symptom 
of the patient’s AVMs was not severe enough to
cause her to seek medical help. It was only after
the patient had her antenatal examinations that
the hypervascular mass of AVMs was detected on
ultrasonography.
Few reports of uterine AVMs in pregnancy can
be found in the literature [12–15]. In some cases,
pregnant patients had profuse uterine bleeding and
required hysterectomy or other kinds of surgical
interventions. Other asymptomatic patients may
have had preterm deliveries. We speculate that the
uterine AVMs in our case developed before our
patient’s last pregnancy and that her subsequent
postpartum hemorrhage may have been highly
related to uterine AVMs. A comprehensive review
of her history and 2D and 3D ultrasonography gave
us an earlier, more definitive diagnosis. Using this
approach enables us to inform patients earlier and
can help lower the complications of uterine AVMs.
Ultrasonography is the tool most commonly
used for investigating abnormal uterine bleeding.
One diagnostic characteristic of uterine AVMs is
subtle myometrial heterogeneity seen on gray-scale
ultrasonography. With color and spectral Doppler
ultrasonography, a tangle of vessels can be seen as
arteriovenous shunting with high-velocity, low-re-
sistance flow [2,16,17]. Castro-Aragon, Timmerman,
Ghi and their colleagues [12,16,17] recommend
that color and spectral Doppler imaging studies
should be performed on all females who had heavy
vaginal bleeding, regardless of findings on gray-
scale ultrasonography. A similar sonographic picture
can be seen in patients with positive beta-hCG
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Fig. 3. The uterine AVM mass was presented and estimated
with 3D ultrasound & VOCAL system. The estimated average
AVM mass volume was 80 cm3.
Fig. 4. Artery-like (more rounded lumen) and vein-like (more
ectatic) vessels and other thin-walled vessels in the background
(hematoxylin & eosin, ×40).
findings. When this sonographic finding and posi-
tive beta-hCG results are present, the diagnosis is
usually pregnancy-related, including intrauterine
pregnancy, ectopic pregnancy, retained products
of conception, or GTD [17].
Treatment of uterine AVMs is based on the clin-
ical status of the patient. Patients with uterine AVMs
who are hemodynamically stable can be treated
conservatively [2,7]. Conservative management of
uterine AVMs includes use of combined oral con-
traceptives, oral methylergonovine maleate, Danazol
(Ladogal) and gonadotropin-releasing hormone
(GnRH) agonists [18–21]. These medications can
reduce estrogen levels and subsequently shrink
uterine AVMs. If patients are anemic or hemody-
namically unstable, interventional therapy may be
necessary.
The most popular method of intervention cited
in the literature is transarterial embolization (TAE)
[7–9]. However, because of the possibility of
embolization to other sites and varying success
rates with TAE, other treatment options can also
be used to manage uterine AVMs. Hysterectomy
was the most common method used to treat uter-
ine AVMs before TAE developed. Other less radical
surgeries, including removal of the AVM lesion,
laparoscopic bipolar coagulation of the uterine
vessels, and unilateral ligation of uterine artery and
ovarian ligaments have been reported [22–23]. 
In our case, the patient preferred a hysterectomy
because she had experienced repeated episodes of
vaginal bleeding in spite of conservative treatment.
Hata et al [24] recommend that 3D ultrasonog-
raphy with power Doppler mapping can be used
to clearly depict the vascular lesion with tangled
vessels in the myometrial layer. Ghi et al [17] also
recommend using this kind of imaging modality.
Both groups propose that 2D and 3D power
Doppler ultrasonography with negative findings of
serum hCG can be used in the differential diagno-
sis of uterine AVMs and other hypervascular lesions
within the myometrium. Our findings were also
compatible with these previous conclusions. Fur-
thermore, we also noted high VI, FI, and VFI mea-
surements in the uterine AVMs under 3D color
power Doppler imaging. These data helped make
the diagnosis of AVMs because of the highly vascu-
lar nature within the myometrial mass. To the best
of our knowledge, our case is the first case diag-
nosed with 2D and 3D ultrasound and actually
confirmed by pathologic examination. Before this,
nearly all cases were confirmed by TAE not patho-
logic examination.
In conclusion, if women have abnormal uterine
bleeding with a heterogeneous myometrial mass,
even in pregnancy, uterine AVMs should be consid-
ered. Using 2D and 3D power Doppler ultrasonog-
raphy can help us correctly make the diagnosis of
uterine AVMs.
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